To the Editor: Larcombe and colleagues1 report a range of potentially harmful chemicals in locally purchased e‐liquids, highlighting the need for rigorous Australian standards and regulation of vaping liquids. However, the biological and clinical significance of these findings is unclear.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Colin Mendelsohn has received funding from Pfizer, GlaxoSmithKline, Johnson and Johnson (Pacific), and Perrigo Australia for teaching, consulting and conference expenses. He is on the Pfizer’s Champix Advisory Board. He has not received any payments from electronic cigarette or tobacco companies. He was the founding chairman of the Australian Tobacco Harm Reduction Association (ATHRA), a health promotion charity established to raise awareness of safer alternatives to smoking, but stepped down from the board in January 2021. ATHRA received funding from the vape industry to establish the charity. Funding was ceased in March 2019. He is the author of a self‐funded book called Stop smoking start vaping. Alex Wodak is currently a director of ATHRA. He has not received any payments from electronic cigarette or tobacco companies.